Short-term administration of SMS 201-995 in the management of an external pancreatic fistula.
A patient presented to the hospital with a persistent high-output (greater than 250 ml/day) external pancreatic fistula after an enucleation of an insulinoma 5 months earlier. Daily treatment with SMS 201-995, a long-acting somatostatin analogue, for 8 days decreased fistulous output to less than 5 ml/day. The patient was discharged in stable condition 9 days after admission. All drainage ceased 2 days later, and the fistula has remained closed. SMS 201-995 has been shown to be effective in decreasing fistulous output of external pancreatic fistulas of various origins. With its few side effects and remarkable effectiveness, SMS 201-995 should be considered in the conservative management of any external pancreatic fistula.
Kwan
D
D
Department of Surgery, Mount Sinai School of Medicine, City University of New York, New York.
Aufses
A H
AH
D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D010185:Pancreatic Fistula / Q000188:drug therapy*
D015282:Octreotide